• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性视网膜病变的人类遗传学。

Human genetics of diabetic retinopathy.

机构信息

Department of Endocrinology and Metabolism, Shanghai Tongji Hospital, Tongji University School of Medicine, Room 517 Building 2nd, NO. 389 Xincun Road, Shanghai, 200063, China,

出版信息

J Endocrinol Invest. 2014 Dec;37(12):1165-74. doi: 10.1007/s40618-014-0172-8. Epub 2014 Sep 9.

DOI:10.1007/s40618-014-0172-8
PMID:25201002
Abstract

There is evidence demonstrating that genetic factors contribute to the risk of diabetic retinopathy (DR). Genetics variants, structural variants (copy number variation, CNV) and epigenetic changes play important roles in the development of DR. Genetic linkage and association studies have uncovered a number of genetic loci and common genetic variants susceptibility to DR. CNV and interactions of gene by environment have also been detected by association analysis. Apart from nucleus genome, mitochondrial DNA plays critical roles in regulation of development of DR. Epigenetic studies have indicated epigenetic changes in chromatin affecting gene transcription in response to environmental stimuli, which provided a large body of evidence of regulating development of diabetes mellitus. Identification of genetic variants and epigenetic changes contributed to risk or protection of DR will benefit uncovering the complex mechanism underlying DR. This review focused on the current knowledge of the genetic and epigenetic basis of DR.

摘要

有证据表明,遗传因素导致糖尿病视网膜病变(DR)的发生风险。遗传变异、结构变异(拷贝数变异,CNV)和表观遗传变化在 DR 的发生发展中发挥重要作用。遗传连锁和关联研究已经发现了一些与 DR 相关的遗传位点和常见遗传变异。通过关联分析还发现了 CNV 和基因-环境相互作用。除核基因组外,线粒体 DNA 在调控 DR 的发生发展中也起着关键作用。表观遗传研究表明,染色质的表观遗传变化影响基因转录以应对环境刺激,这为调节糖尿病发生发展的机制提供了大量证据。鉴定与 DR 的风险或保护相关的遗传变异和表观遗传变化将有助于揭示 DR 的复杂机制。本综述重点介绍了 DR 的遗传和表观遗传基础的最新知识。

相似文献

1
Human genetics of diabetic retinopathy.糖尿病性视网膜病变的人类遗传学。
J Endocrinol Invest. 2014 Dec;37(12):1165-74. doi: 10.1007/s40618-014-0172-8. Epub 2014 Sep 9.
2
Human genetics of diabetic nephropathy.糖尿病肾病的人类遗传学
Ren Fail. 2015 Apr;37(3):363-71. doi: 10.3109/0886022X.2014.1000801. Epub 2015 Jan 16.
3
Human genetics of diabetic vascular complications.糖尿病血管并发症的人类遗传学
J Genet. 2013 Dec;92(3):677-94. doi: 10.1007/s12041-013-0288-1.
4
Genotypes and Phenotypes: A Search for Influential Genes in Diabetic Retinopathy.基因型与表型:探寻糖尿病视网膜病变中的相关基因
Int J Mol Sci. 2020 Apr 14;21(8):2712. doi: 10.3390/ijms21082712.
5
Role of histone modification and DNA methylation in signaling pathways involved in diabetic retinopathy.组蛋白修饰和 DNA 甲基化在糖尿病视网膜病变相关信号通路中的作用。
J Cell Physiol. 2019 Jun;234(6):7839-7846. doi: 10.1002/jcp.27844. Epub 2018 Dec 4.
6
Genome-wide analysis of DNA methylation identifies S100A13 as an epigenetic biomarker in individuals with chronic (≥ 30 years) type 2 diabetes without diabetic retinopathy.全基因组 DNA 甲基化分析鉴定出 S100A13 是慢性(≥30 年)2 型糖尿病而无糖尿病视网膜病变个体的表观遗传生物标志物。
Clin Epigenetics. 2020 Jun 3;12(1):77. doi: 10.1186/s13148-020-00871-z.
7
Targeting epigenetic modifications as a potential therapeutic option for diabetic retinopathy.针对表观遗传修饰作为糖尿病性视网膜病变潜在治疗选择的研究进展。
J Cell Physiol. 2020 Mar;235(3):1933-1947. doi: 10.1002/jcp.29180. Epub 2019 Sep 17.
8
Candidate gene studies of diabetic retinopathy in human.人类糖尿病视网膜病变的候选基因研究。
Mol Biol Rep. 2016 Dec;43(12):1327-1345. doi: 10.1007/s11033-016-4075-y. Epub 2016 Oct 11.
9
Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy.对1型糖尿病患者进行全基因组DNA甲基化分析,确定了与增殖性糖尿病视网膜病变相关的表观遗传修饰。
BMC Med. 2015 Aug 6;13:182. doi: 10.1186/s12916-015-0421-5.
10
Replication of genetic loci implicated in diabetic retinopathy.遗传位点在糖尿病视网膜病变中的复制。
Invest Ophthalmol Vis Sci. 2014 Mar 19;55(3):1666-71. doi: 10.1167/iovs.13-13559.

引用本文的文献

1
New insights of potential biomarkers in diabetic retinopathy: integrated multi-omic analyses.糖尿病视网膜病变潜在生物标志物的新见解:综合多组学分析
Front Endocrinol (Lausanne). 2025 Jul 1;16:1595207. doi: 10.3389/fendo.2025.1595207. eCollection 2025.
2
Polymorphisms in HIF-1a gene are not associated with diabetic retinopathy in China.在中国,低氧诱导因子-1α(HIF-1α)基因多态性与糖尿病视网膜病变无关。
World J Diabetes. 2021 Aug 15;12(8):1304-1311. doi: 10.4239/wjd.v12.i8.1304.
3
Genetics of Diabetic Retinopathy.糖尿病视网膜病变的遗传学研究。

本文引用的文献

1
Genome-wide analysis of copy number variation in type 1 diabetes.1 型糖尿病中拷贝数变异的全基因组分析。
PLoS One. 2010 Nov 15;5(11):e15393. doi: 10.1371/journal.pone.0015393.
2
Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus.1 型糖尿病糖尿病肾病的全基因组 DNA 甲基化分析。
BMC Med Genomics. 2010 Aug 5;3:33. doi: 10.1186/1755-8794-3-33.
3
miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes.miR-1/miR-206 调节 Hsp60 的表达,促进葡萄糖介导的心肌细胞凋亡。
Curr Diab Rep. 2019 Jul 29;19(9):67. doi: 10.1007/s11892-019-1186-6.
4
Diabetic Retinopathy: Animal Models, Therapies, and Perspectives.糖尿病视网膜病变:动物模型、治疗方法及展望
J Diabetes Res. 2016;2016:3789217. doi: 10.1155/2016/3789217. Epub 2016 Jan 6.
5
GSTM1 and GSTT1 null genotype and diabetic retinopathy: a meta-analysis.谷胱甘肽S-转移酶M1和谷胱甘肽S-转移酶T1无效基因型与糖尿病视网膜病变:一项荟萃分析。
Int J Clin Exp Med. 2015 Feb 15;8(2):1677-83. eCollection 2015.
FEBS Lett. 2010 Aug 20;584(16):3592-600. doi: 10.1016/j.febslet.2010.07.027. Epub 2010 Jul 24.
4
Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes.血浆 microRNA 谱分析显示 2 型糖尿病中内皮细胞 miR-126 和其他 microRNAs 的丢失。
Circ Res. 2010 Sep 17;107(6):810-7. doi: 10.1161/CIRCRESAHA.110.226357. Epub 2010 Jul 22.
5
Circulating microRNAs in patients with coronary artery disease.冠心病患者循环 microRNAs。
Circ Res. 2010 Sep 3;107(5):677-84. doi: 10.1161/CIRCRESAHA.109.215566. Epub 2010 Jul 1.
6
Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes.体内 microRNA 变化的整合鉴定了 2 型糖尿病肌肉胰岛素抵抗的新分子特征。
Genome Med. 2010 Feb 1;2(2):9. doi: 10.1186/gm130.
7
Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes.肾衰竭会增加 2 型糖尿病患者心脏组蛋白 h3 的乙酰化、二甲基化和磷酸化,并诱导与心肌病相关的基因。
Am J Pathol. 2010 Mar;176(3):1079-83. doi: 10.2353/ajpath.2010.090528. Epub 2010 Jan 14.
8
Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10.2 型糖尿病中进行性肾小球硬化与肾组织组蛋白 H3K9 和 H3K23 乙酰化、H3K4 二甲基化以及丝氨酸 10 磷酸化有关。
Nephrol Dial Transplant. 2010 Jun;25(6):1811-7. doi: 10.1093/ndt/gfp730. Epub 2010 Jan 12.
9
miR133a regulates cardiomyocyte hypertrophy in diabetes.miR133a 调控糖尿病中的心肌细胞肥大。
Diabetes Metab Res Rev. 2010 Jan;26(1):40-9. doi: 10.1002/dmrr.1054.
10
Exome sequencing identifies the cause of a mendelian disorder.外显子组测序确定了一种孟德尔疾病的病因。
Nat Genet. 2010 Jan;42(1):30-5. doi: 10.1038/ng.499. Epub 2009 Nov 13.